<--- Back to Details
First PageDocument Content
Health / Deep vein thrombosis / Enoxaparin sodium / Fondaparinux / Low molecular weight heparin / Reperfusion therapy / Thrombocytopenia / Thrombosis / Pulmonary embolism / Heparins / Medicine / Blood
Date: 2013-07-29 16:00:10
Health
Deep vein thrombosis
Enoxaparin sodium
Fondaparinux
Low molecular weight heparin
Reperfusion therapy
Thrombocytopenia
Thrombosis
Pulmonary embolism
Heparins
Medicine
Blood

Microsoft Word - Arixtra_PM _2013-07-12_.doc

Add to Reading List

Source URL: www.gsk.ca

Download Document from Source Website

File Size: 356,33 KB

Share Document on Facebook

Similar Documents

Medicine / Health care / Clinical medicine / Anesthesia / Medical specialties / Heparins / American Society of Anesthesiologists / Intensivist / Low molecular weight heparin / Aryeh Shander / Society of Critical Care Medicine / Intensive care medicine

A M E R I C A N S O C I E T Y O F

DocID: 1qkK5 - View Document

Glycosaminoglycans / Heparins / cole Normale Suprieure / Heparan sulfate / ITMO University

Monday October 10th, 2016 Amphitheatre xxx The success story of a carbohydrate” ENS Paris 29 rue d’Ulm ITMO Molecular and structural basis of life Paris 5ème

DocID: 1ptev - View Document

Anticoagulants / Hematology / Lactams / Heparins / Morpholines / Rivaroxaban / Venous thrombosis / Thrombosis / Low molecular weight heparin / Direct Xa inhibitor / Surgery / Apixaban

SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv

DocID: 1p0MX - View Document

Rivaroxaban / Low molecular weight heparin / Factor X / Fondaparinux / Heparins / Chemistry / Organic chemistry

April 21st, 2015 Kits for which Material Safety Data Sheets are not required The kits listed below are not labelled as hazardous. Considering the Regulation (EC) N° and the OSHA regulations 29 CFRg

DocID: 1gtqX - View Document

Guideline on non-clinical and clinical development of similar biological medicinal products containing low molecular-weight-heparins

DocID: 1cDQr - View Document